From Healthing:

“The body responsible for pricing patented drugs in Canada — the Patented Medicine Prices Review Board (PMPRB) — has proposed changes to lower the cost of drugs, which are scheduled to come into effect in January 2022. While the idea of lowering drug prices might seem like a good idea, experts warn there’s more to the story, and lower costs could mean delayed access, or worse — no access at all — to novel drug therapies for Canadians.”


To read the entire article, please go to: